UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes

European journal of human genetics : EJHG, 2020-10, Vol.28 (10), p.1379-1386

2020

Volltextzugriff (PDF)

Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival

ESMO open, 2024-07, Vol.9 (7), p.103617, Article 103617

2024

Volltextzugriff (PDF)

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

European journal of human genetics : EJHG, 2020-10, Vol.28 (10), p.1387-1393

2020

Volltextzugriff (PDF)

26O Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival

ESMO open, 2024-03, Vol.9, p.102415, Article 102415

2024

Volltextzugriff (PDF)

Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome

European journal of human genetics : EJHG, 2023-11, Vol.31 (11), p.1261-1269

2023

Volltextzugriff (PDF)

Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives

European journal of human genetics : EJHG, 2024-01, Vol.32 (1), p.6-7

2024

Volltextzugriff (PDF)

Whole‐body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study

Cancer, 2023-03, Vol.129 (6), p.946-955

2023

Volltextzugriff (PDF)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

International journal of cancer, 2019-03, Vol.144 (5), p.1195-1204

2019

Volltextzugriff (PDF)

Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies

Cancers, 2022-09, Vol.14 (19), p.4665

2022

Volltextzugriff (PDF)

Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5

The Journal of biological chemistry, 1994-04, Vol.269 (14), p.10891-10898

1994

Volltextzugriff (PDF)

Functional characterization of novel germline TP53 variants in Swedish families

Clinical genetics, 2019-09, Vol.96 (3), p.216-225

2019

Volltextzugriff (PDF)

Prediction of breast cancer risk for sisters of women attending screening

JNCI : Journal of the National Cancer Institute, 2023-11, Vol.115 (11), p.1310-1317

2023

Volltextzugriff (PDF)

Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6345

2021

Volltextzugriff (PDF)

Germline TP53 Testing in Breast Cancers: Why, When and How?

Cancers, 2020-12, Vol.12 (12), p.3762

2020

Volltextzugriff (PDF)

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

Familial cancer, 2019-04, Vol.18 (2), p.281-284

2019

Volltextzugriff (PDF)

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer

Journal of ovarian research, 2016-05, Vol.9 (1), p.27, Article 27

2016

Volltextzugriff (PDF)

Investigation of Genetic Alterations Associated With Interval Breast Cancer

JAMA oncology, 2024-03, Vol.10 (3), p.372

2024

Volltextzugriff (PDF)

Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells

Oncotarget, 2016-06, Vol.7 (24), p.35703-35723

2016

Volltextzugriff (PDF)

Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53 -Related Cancer Syndrome Study (SWEP53)

Cancers, 2022-01, Vol.14 (2), p.380

2022

Volltextzugriff (PDF)

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53

Hereditary cancer in clinical practice, 2020-01, Vol.18 (1), p.1-1, Article 1

2020

Volltextzugriff (PDF)

Whole-Exome Sequencing of Germline Variants in Non- BRCA Families with Hereditary Breast Cancer

Biomedicines, 2022-04, Vol.10 (5), p.1004

2022

Volltextzugriff (PDF)

The first genotype-phenotype study on European carriers of CDH1 germline mutations

EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, Vol.28 (SUPPL 1), p.61

2020

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(45)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Journal Of Human Genetics
(5)
European Journal Of Human Genetics : Ejhg
(5)
Genes Chromosomes & Cancer
(4)
Cancers
(3)
Human Genetics
(3)
Chromosome Research
(2)
Clinical Genetics
(2)
Esmo Open
(2)
Oncotarget
(2)
Plos One
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes

Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

26O Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal

Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome

Public attitudes challenge clinical practice on genetic risk disclosure in favour of healthcare-provided direct dissemination to relatives

Whole‐body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies

Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5

Functional characterization of novel germline TP53 variants in Swedish families

Prediction of breast cancer risk for sisters of women attending screening

Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer

Germline TP53 Testing in Breast Cancers: Why, When and How?

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer

Investigation of Genetic Alterations Associated With Interval Breast Cancer

Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells

Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53 -Related Cancer Syndrome Study (SWEP53)

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53

Whole-Exome Sequencing of Germline Variants in Non- BRCA Families with Hereditary Breast Cancer

GENOTYPE-PHENOTYPE ASSOCIATIONS PROVIDE A RATIONAL TO IDENTIFY POTENTIALLY ACTIONABLE VUS

The first genotype-phenotype study on European carriers of CDH1 germline mutations

Aktive Filter

Suchergebnisse filtern